Why Mead Johnson Nutrition CO (MJN), Boston Scientific Corporation (BSX), And 2 Other Stocks Might Be Right For Your Portfolio
Despite of all the negative sentiment looming around them, hedge funds had a pretty solid run for much of this year.
Hedge Fund - Blue Jay Capital Management
Get Email AlertsPaul Sinclair Bio, Returns, AUM, Net Worth
Manager biography is currently missing.
Fund Profile
Filing Period:
| Fund Name: | Blue Jay Capital Management |
| Manager | Paul Sinclair |
| Portfolio Value | $146,758,000 |
| Change This QTR | +0.72% |
Top 13F Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | TSRO | 67,490 | $9,439,000 | -21% | 6.43% | ||
| 2. | CLVS | 99,101 | $9,279,000 | -34% | 6.32% | ||
| 3. | INCY | 72,051 | $9,072,000 | +4% | 6.18% | ||
| 4. | IRWD | 561,180 | $8,874,000 | -31% | 6.04% | ||
| 5. | WMGI | 320,420 | $8,808,000 | +5% | 6% |
News, Interviews and Investor Letters
Blue Jay Capital Betting On Big Returns From These Healthcare Stocks
Founded by Paul Sinclair in August 2014, Blue Jay Capital Management is a healthcare-focused hedge fund based in California.
Top New Picks of Healthcare Fund Blue Jay Capital: Endo International plc (ENDP), Alkermes Plc (ALKS), Akorn Inc. (AKRX)
Healthcare-focused fund Blue Jay Capital Management, managed by Paul Sinclair, has disclosed its equity portfolio for the reporting period of March 31 in a 13F filed with the U.S.
Receptos Inc (RCPT), Centene Corp (CNC): Paul Sinclair Flying High With New Fund's Top Healthcare Picks
Paul Sinclair's newly established healthcare-focused fund, Blue Jay Capital Management posted an impressive 12% return during the first quarter, significantly outperforming the S&P 500 ETF (SPY) that ...
